Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences and Leuven Research Institute for Neuroscience and Disease (LIND), KU Leuven, Flanders, Belgium.
Trends Mol Med. 2013 Jun;19(6):368-77. doi: 10.1016/j.molmed.2013.04.002. Epub 2013 May 3.
The aggregation of the protein alpha-synuclein (α-SYN) is believed to be a critical event in Parkinson's disease (PD). α-SYN is characterized by a remarkable conformational plasticity, adopting different conformations depending on the environment. In vitro, α-SYN lacks a well-defined structure. Therefore, it was classified as an 'intrinsically disordered protein'. A debate has recently begun over how α-SYN behaves in the cell: is it an intrinsically disordered protein or a stable tetramer with a low propensity for aggregation? In this review, we discuss the aggregation of α-SYN and describe factors that influence this process and their potential relevance in PD pathogenesis. We address the ways in which aggregated α-SYN mediates toxicity and might lead to PD, and propose possible therapeutic strategies.
蛋白质α-突触核蛋白(α-SYN)的聚集被认为是帕金森病(PD)的一个关键事件。α-SYN 的特点是具有显著的构象可塑性,根据环境的不同,采用不同的构象。在体外,α-SYN 缺乏明确的结构。因此,它被归类为“无规卷曲蛋白质”。最近,人们开始争论α-SYN 在细胞中的行为方式:它是无规卷曲蛋白质还是具有低聚集倾向的稳定四聚体?在这篇综述中,我们讨论了α-SYN 的聚集,并描述了影响这一过程的因素及其在 PD 发病机制中的潜在相关性。我们探讨了聚集的α-SYN 介导毒性的方式,并可能导致 PD,提出了可能的治疗策略。